Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.16B |
| 2 |
Eli Lilly
LLY
|
+$1.9B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.09B |
| 4 |
Cigna
CI
|
+$883M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.49B |
| 2 |
Comcast
CMCSA
|
+$1.34B |
| 3 |
Stryker
SYK
|
+$1.31B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
| 5 |
Walt Disney
DIS
|
+$1.2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.6% |
| 2 | Healthcare | 16.48% |
| 3 | Financials | 12.48% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Communication Services | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Smith & Wesson
SWBI
$636M
| $23.4M | ﹤0.01% |
3,670,485
-814,126
| -18% | -$5.76M |
|
1327
Globe Life
GL
$14.2B
| $23.3M | ﹤0.01% |
324,344
-427,072
| -57% | -$40.3M |
|
1328
Hanmi Financial
HAFC
$939M
| $23.3M | ﹤0.01% |
2,146,952
+121,740
| +6% | +$1.94M |
|
|
UMH
1329
UMH Properties
UMH
$1.34B
| $23.2M | ﹤0.01% |
2,137,758
-427,631
| -17% | -$6.21M |
|
1330
Cactus
WHD
$5.7B
| $23.2M | ﹤0.01% |
2,000,804
+659,487
| +49% | +$16.6M |
|
1331
Clarus
CLAR
$145M
| $23.2M | ﹤0.01% |
2,376,716
+158,301
| +7% | +$1.91M |
|
1332
RPM International
RPM
$14.8B
| $23.2M | ﹤0.01% |
389,241
+382,765
| +5,911% | +$26.4M |
|
1333
Itron
ITRI
$4.49B
| $23.1M | ﹤0.01% |
413,055
-56,633
| -12% | -$4.3M |
|
1334
Viper Energy
VNOM
$15.3B
| $23M | ﹤0.01% |
3,467,951
-4,183,558
| -55% | -$76M |
|
1335
CoreCivic
CXW
$3.26B
| $22.9M | ﹤0.01% |
2,048,951
+269,119
| +15% | +$4.03M |
|
1336
RELX
RELX
$62.1B
| $22.7M | ﹤0.01% |
1,061,936
+901,965
| +564% | +$21.9M |
|
|
SOLN
1337
DELISTED
The Southern Company
SOLN
| $22.6M | ﹤0.01% |
509,400
+58,000
| +13% | +$3.04M |
|
1338
Vanguard S&P 500 ETF
VOO
$1.03T
| $22.5M | ﹤0.01% |
95,192
-11,385
| -11% | -$3.19M |
|
1339
Avantor
AVTR
$9.29B
| $22.5M | ﹤0.01% |
1,804,103
-2,906,040
| -62% | -$46.6M |
|
1340
Rush Enterprises Class A
RUSHA
$6.23B
| $22.5M | ﹤0.01% |
1,583,354
+683,176
| +76% | +$12.3M |
|
1341
OR Royalties Inc
OR
$6.32B
| $22.4M | ﹤0.01% |
3,000,001
+2,999,999
| +149,999,950% | +$26.7M |
|
1342
Republic Services
RSG
$65.7B
| $22.3M | ﹤0.01% |
297,264
+27,753
| +10% | +$2.51M |
|
1343
CRA International
CRAI
$1.06B
| $22.3M | ﹤0.01% |
666,053
+137,442
| +26% | +$6.55M |
|
|
CLLS
1344
Cellectis
CLLS
$278M
| $22.2M | ﹤0.01% |
2,415,035
-768,911
| -24% | -$11.5M |
|
1345
Ambarella
AMBA
$3.6B
| $22.2M | ﹤0.01% |
456,234
-191,122
| -30% | -$11M |
|
|
ARD
1346
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $22.1M | ﹤0.01% |
1,866,076
+190,755
| +11% | +$3.35M |
|
1347
Apple Hospitality REIT
APLE
$3.71B
| $22M | ﹤0.01% |
2,401,725
+79,608
| +3% | +$1.05M |
|
1348
iShares S&P 100 ETF
OEF
$20.5B
| $22M | ﹤0.01% |
185,439
-5,206
| -3% | -$717K |
|
|
ALTR
1349
DELISTED
Altair Engineering Inc
ALTR
| $22M | ﹤0.01% |
829,514
-368,902
| -31% | -$12.6M |
|
1350
Seres Therapeutics
MCRB
$50.2M
| $22M | ﹤0.01% |
307,487
-17,469
| -5% | -$1.17M |
|
Similar funds
Fidelity Investments's Q1 2020 Portfolio in Review
As of Q1 2020, Fidelity Investments held 4,600 positions worth $722B, down 20% from $906B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Fidelity Investments's Q1 2020 filing shows 372 new, 1,381 increased, 1,824 reduced and 431 closed positions. Its largest new stake was 1Life Healthcare: 9,509,562 shares worth $164M. The largest sale was Amgen, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Fidelity Investments's largest Q1 2020 buy was 1Life Healthcare: 9,509,562 shares worth $164M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q1 2020, an estimated $2.16B increase.
- Fidelity Investments's biggest Q1 2020 reduction was Amgen, cutting an estimated $1.49B.
- Fidelity Investments fully exited Taubman Centers Inc. in Q1 2020, selling an estimated $106M.
- Fidelity Investments's ten largest holdings make up 27% of its $722B portfolio in Q1 2020.
- Fidelity Investments opened 372 new positions and closed 431 in Q1 2020.
- Fidelity Investments's portfolio value fell 20% quarter-over-quarter to $722B.
Based on Fidelity Investments's 13F filing for Q1 2020, filed 14 May 2020.